Phase
Condition
Multiple Sclerosis
Memory Loss
Scar Tissue
Treatment
Transcutaneous electrical nerve stimulation
Clinical Study ID
Ages 18-65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Men and women18-65 yrs
Able to read, understand, and speak English to ensure safe participation in theproject
Clinical diagnosis of relapsing-remitting MS
Self-reported difficulty with walking
On stable doses of Ampyra, provigil, or other symptomatic-treating medications
No relapse or systemic steroids within the last 30 days
Able to arrange transportation to the Boulder campus
Exclusion
Exclusion Criteria:
Vision or hearing problems that have not been corrected
Problems with sensations to temperature, pressure, or pain
Any arm or leg problems that would influence the ability to hold a weight
Surgery to the arms or legs that continues to bother the participant
Metal implants
Medical diagnosis or condition that is considered to be an absolute or relativecontraindication to participating in exercise training, such as major renal,pulmonary, hepatic, cardiac, gastrointestinal, HIV, cancer (other than treated basalcell cancer), other neurological disorders, or pregnancy
History of head injury or stroke
Taking antidepressants, anticholinergics, stimulants, sedatives, cannabis, illicitdrugs or medications to treat herpes or neurologic pain.
Diagnosis of diabetes mellitus
Poorly controlled hypertension
History of seizure disorders
≥2 alcoholic drinks/day, or present history (last 6 months) of drug abuse
Spasticity that requires the individual to change intended activities more oftenthan once a week
Skin diseases or sensation problems in the legs or hands that influences someactivities more often than once a week
Inability to attend exercise sessions 3 days per week for 6 weeks
Study Design
Study Description
Connect with a study center
University of Colorado
Boulder, Colorado 80309
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.